FDA Warning Letter To Cordis: Controls Lacking To Ensure Stent Quality
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/Cordis released units of its Cypher drug-eluting stent to the market even though stents in some lots were shown by internal company testing not to expand completely, according to an FDA warning letter.